Biomea Fusion, Inc.
BMEA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840439
No open-market purchases or sales by Biomea Fusion, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Holders of 5% or more of BMEA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biomea Fusion, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 13G/A | 9.90%7.85M shares | 0.00 ppfrom 9.90% | Jun 25, 20253 filings | Feb 17, 2026 | SEC |
| Blue Owl Capital Holdings LP | 13G | 5.92%4.45M shares | +2.50 ppfrom 3.42% | Aug 11, 20253 filings | Feb 12, 2026 | SEC |
| Janus Henderson Group PLC | 13G | 5.00%3.75M shares | New | Dec 8, 20251 filing | Dec 8, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
14 Schedule 13D and 13G filings on Biomea Fusion, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20262:46 PM ET | CVI Investments, Inc.and 1 other | 13G/A | 9.90%7.85M shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Feb 12, 20264:02 PM ET | Blue Owl Capital Holdings LP | 13G | 5.92%4.45M shares | +2.50 ppfrom 3.42% | Dec 31, 2025 | SEC |
| Feb 6, 20264:30 PM ET | Erdtmann Rainer M | 13G/A | 3.90%2.78M shares | −1.30 ppfrom 5.20%Below 5% | Dec 31, 2025 | SEC |
| Dec 8, 202511:44 AM ET | Janus Henderson Group PLC | 13G | 5.00%3.75M shares | New | Nov 28, 2025 | SEC |
| Nov 14, 20254:05 PM ET | Blue Owl Capital Holdings LP | 13G/A | 3.42%2.50M shares | −2.71 ppfrom 6.13%Below 5% | Sep 30, 2025 | SEC |
| Nov 7, 20254:48 PM ET | CVI Investments, Inc.and 1 other | 13G/A | 9.90%6.45M shares | 0.00 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Oct 24, 20254:10 PM ET | Cormorant Asset Management, LPand 5 others | 13D/A | 1.53%1.06M shares | −3.78 ppfrom 5.31%Below 5% | Oct 22, 2025 | SEC |
| Oct 10, 20254:06 PM ET | Cormorant Asset Management, LPand 5 others | 13D/A | 5.31%3.68M shares | −1.15 ppfrom 6.46% | Oct 8, 2025 | SEC |
| Aug 13, 20254:30 PM ET | Erdtmann Rainer Mand 2 others | 13G/A | 5.20%2.98M shares | – | Jun 30, 2025 | SEC |
| Aug 11, 20255:57 PM ET | Blue Owl Capital Holdings LP | 13G | 6.13%3.80M shares | New | Jun 30, 2025 | SEC |
| Jul 22, 20255:15 PM ET | Cormorant Asset Management, LPand 5 others | 13D/A | 6.46%3.68M shares | – | Jun 20, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 1.30%753.6K shares | –Below 5% | Jun 30, 2025 | SEC |
| Jun 25, 202510:17 AM ET | CVI Investments, Inc.and 1 other | 13G | 9.90%5.83M shares | New | Jun 17, 2025 | SEC |
| Feb 14, 20254:12 PM ET | Baker Bros. Advisors LPand 3 others | 13G/A | 4.00%1.45M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Biomea Fusion, Inc. shares.
No Form 144 notices for Biomea Fusion, Inc. are on file.